Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot study - Concepedia

Concepedia

Publication | Open Access

Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot study

DOI Full Paper Access

41

Citations

22

References

2006

Year

Gaetano Corazzelli, Filippo Russo, Giampiero Capobianco, Gianpaolo Marcacci, Paola Della Cioppa, Antonio Pinto

Annals of Oncology

Lymphoid NeoplasiaRefractory Aggressive Non-hodgkinMedicinePathologyCancer TreatmentImmunotherapyOncologyRadiation OncologyCancer ResearchPilot Study

References

	Year	Citations

Page 1